Infertility as a Cancer Risk Factor - A Review

Placenta

Volumn 29, Issue SUPPL.2, 2008, Pages 169-177

  Cetin, I ^a   Cozzi, V ^a   Antonazzo, P ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Cancer risk; Fertility drugs; Infertility

Indexed keywords

CLOMIFENE; CLOMIFENE CITRATE; ESTROGEN; FOLLITROPIN; GONADOTROPIN; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; PROGESTERONE; SOMATOMEDIN C; TAMOXIFEN;

ARTICLE; BREAST CANCER; CANCER INCIDENCE; CANCER INVASION; CANCER PATIENT; CANCER RISK; CELL FUNCTION; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; DRUG MECHANISM; ENDOMETRIOSIS; ENDOMETRIUM CANCER; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HORMONE ACTION; HUMAN; INFERTILITY THERAPY; MELANOMA; MENARCHE; MENOPAUSE; NULLIPARA; OVARY CANCER; OVARY INSUFFICIENCY; OVARY TUMOR; OVULATION INDUCTION; PRIORITY JOURNAL; RISK FACTOR; THYROID CANCER; TREATMENT DURATION; UTERINE CERVIX CANCER;

BREAST NEOPLASMS; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; INFERTILITY, FEMALE; MODELS, BIOLOGICAL; NEOPLASMS; OVARIAN NEOPLASMS; OVULATION INDUCTION; RISK FACTORS;

EID: 51549115056     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.08.007     Document Type: Article

References (66)

1. Brinton L.A., Melton III L.J., Malkasian Jr. G.D., Bond A., and Hoover R. Cancer risk after evaluation for infertility. Am J Epidemiol 129 (1989) 712-722
2. Venn A., Watson L., Bruinsma F., Giles G., and Healy D. Risk of cancer after use of infertility drugs with in-vitro fertilization. Lancet 354 (1999) 1586-1590
3. Potashnik G., lerner-geva L., Genkin L., Chetrit A., Lunenfeld E., and Porath A. Fertility drugs and the risk of breast and ovarian cancers: results of a long-term follow-up study. Fertil Steril 71 (1999) 853-859
4. Modan B., Ron E., Lerner-Geva L., Blumstein T., Menczer J., Rabinovivi J., et al. Cancer incidence in a color of infertile women. Am J Epidemiol 147 (1998) 1038-1042
5. Brinton L.A., Lamb E.J., Moghissi K.S., Scoccia B., Althuis M.D., Mabie J., et al. Ovarian cancer risk associated with varying causes of infertility. Fertil Steril 82 (2004) 405-414
6. Rossing M.A., Daling J.R., Weiss N.S., Moore D.E., and Self S.G. Ovarian tumors in a cohort of infertile women. N Engl J Med 331 (1994) 771-776
7. Harlow B.L., Weiss N.S., Roth G.S., Chu J., and Daling J.R. Case-control study of borderline ovarian tumors: reproductive history and exposure to exogenous female hormones. Cancer Res 48 (1988) 5849-5852
8. Tworoger S.S., Fairfield K.M., Colditz G.A., Rosner B.A., and Hankinson S.E. Association of oral contraceptive use, other contraceptive methods, and infertility with ovarian cancer risk. Am J Epidemiol 166 (2007) 894-901
9. Jensen A., Sharif H., Jorgen H.O., and Kruger Kjaer S. Risk of breast cancer and gynecologic cancers in a large population of nearly 50,000 infertile Danish women. Am J Epidemiol 16 7 (2007) 1400-1407
10. Whittemore A., Harris R., and Itnyre J. The collaborative Ovarian Cancer Group. Characteristics relating to ovarian cancer risk: collaborative analysis of 12 US case-control studies. II. Invasive epithelial ovarian cancers in white women. Am J Epidemiol 135 (1992) 1184-1203
11. Ness R.B., Cramer D.W., Goodman M.T., Kjaer S.K., Mallin N., Mosgaard B.J., et al. Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol 155 (2002) 217-224
12. Rossing M.A., Tang M.T., Flagg E.W., Weiss L.K., and Wicklund K.G. A case-control study of ovarian cancer in relation to infertility and the use of ovulation induction drugs. Am J Epidemiol 160 (2004) 1070-1078
13. Schildkraut J.M., Schwingl P.J., Bastos E., Evanoff A., and Hughes C. Epithelial ovarian cancer risk among women with polycystic ovary syndrome. Obstet Gynecol 88 (1996) 554-559
14. Ron E., Lunenfeld B., Menczer J., Blumemstein T., katz L., Oelsner G., et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 125 (1987) 780-790
15. Melin A., Sparen P., and Bergquist A. The risk of cancer and the role of parity among women with endometriosis. Hum Reprod 22 (2007) 3021-3026
16. Brinton L.A., Gridley G., Person I., Baron J., and Bergqvist A. Cancer risk after a hospital discharge diagnosis of endometriosis. Am J Obstet Gynecol 176 (1997) 572-579
17. Berglund AS, Sparen O, Bergqvist A. Endometriosis and the risk of ovarian cancer. Abstract of the 19th Annual Meeting of ESHRE, Madrid, Hum Reprod, Abstract Book; 2003.
18. Vercellini P., Parazzini F., Bolis G., Carinelli S., Dindelli M., Vendola N., et al. Endometriosis and ovarian cancer. Am J Obstet Gynecol 169 (1993) 181-182
19. Ogawa S., Kuku T., Amada S., Kobayashi H., Hirakawa T., Ariyoshi K., et al. Ovarian endometriosis associated with ovarian carcinoma: a clinic-pathological and immunohistochemical study. Gynecol Oncol 77 (2000) 298-304
20. Oral E., Ilvan S., Tustas E., Korbeyli B., Bese T., Demirkiran F., et al. Prevalence of endometriosis in epithelial ovary tumors. Eur J Obstet Gynecol Reprod Biol 109 (2003) 97-101
21. Garland M., hunter D.J., Coldhits G.A., Manson J.E., Stampfer M.J., Spiegelman D., et al. Menstrual cycle characteristics and history of ovulation infertility in relation to breast cancer risk in a large cohort of US women. Am J Epidemiol 147 (1998) 636-642
22. Anderson K.E., Sellers T.A., Chen P.-L., Rich S.S., Hong C.P., and Folsom A.R. Association of Stein-Leventhal syndrome with the incidence of postmenopausal breast carcinoma in large prospective study of women in IOWA. Cancer 79 (1997) 494-499
23. Terry K.L., Willet W.C., Rich-Edwards J.W., et al. A prospective study of infertility due to ovulatory disorders, ovulation induction, and incidence of breast cancer. Arch Intern Med 166 (2006) 2484-2489
24. Gammon M.D., and Thompson W.D. Polycystic ovaries and the risk of breast cancer. Am J Epidemiol 134 (1991) 818-824
25. Moseson M., Koenig K.L., Shore R.E., and Pasternack B.S. The influence of medical conditions associated with hormones on the risk of breast cancer. Int J Epidemiol 22 (1993) 1000-1009
26. Weiss H.A., Brinton L.A., Potishman N.A., Brogan D., Coates R.J., Gammon M.D., et al. Breast cancer risk in young women and history of selected medical conditions. Int J Epidemiol 28 (1999) 816-823
27. Ness R.B., and Modugno F. Endometriosis as a model for inflammation-hormone interactions in ovarian and breast cancer. Eur J Cancer 42 (2006) 691-703
28. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 19 (2004) 41-47
29. Giudice L.C. Endometrium in PCOS: implantation and predisposition to endocrine CA. Best Pract Res Clin Endocrinol Metab 20 (2006) 235-244
30. Speert H. Carcinoma of the endometrium in young women. Surg Gynecol Obstet 88 (1949) 332-336
31. Jackson R.L., and Docherty M.B. The Stein-Leventhal syndrome: analysis of 43 cases with special references to association with endometrial carcinoma. Am J Obstet Gynecol 73 (1957) 161-173
32. Hardiman P., Pillary O.C., and Atiomo W. Polycystic ovary syndrome and endometrial carcinoma. Lancet 361 (2003) 1810-1812
33. Peirpoint T., McKeigue P.M., Isaacs A.J., Wild S.H., and Jacobs H.S. Mortality of women with polycystic ovary syndrome at long-term follow-up. J Clin Epidemiol 51 (1998) 581-586
34. Jafari K., Javaheri G., and Ruiz G. Endometrial adenocarcinoma and the Stein-Leventhal Syndrome. Obstet Gynecol 51 (1978) 97-100
35. Pillay O.C., Wong Te Fong L.F., Crow J.C., Benjiamin E., Mould T., Atiomo W., et al. The association between polycystic ovaries and endometrial cancer. Human Reprod 21 (2006) 924-929
36. Rossing M., Daling J., Weiss N., Moore D., and Self S. In situ and invasive cervical carcinoma in a cohort of infertile women. Fertil Steril 65 (1996) 19-22
37. Venn A., Watson L., Lumley J., Giles G., King C., and Healy D. Breast and ovarian cancer incidence after infertility and in vitro fertilization. Lancet 346 (1995) 995-1000
38. Rossing M., Daling J., Weiss N., Moore D., and Self S. Risk of cutaneous melanoma in a cohort of infertile women. Melanoma Res 5 (1995) 123-127
39. Brinton L.A., Westhoff C.L., Scoccia B., Lamb E.J., Althiuus M.D., Mabie J.E., et al. Causes of infertility as predictors of subsequent cancer risk. Epidemiology 11 (2005) 111-117
40. Booth M., Beral V., and Smith P. Risk factors for ovarian cancer: a case-control study. Br J Cancer 60 (1989) 592-598
41. Fathalla M.F. Incessant ovulation - a factor in ovarian neoplasia?. Lancet 2 (1971) 163
42. Risch H.A. Hormonal etiology of epithelial ovarian cancer, with a hypothesis concerning the role of androgens and progesterone. J Natl Cancer Inst 90 (1998) 1774-1786
43. Cook L.S., Kamb M.L., and Weiss N.S. Perineal powder exposure and the risk of ovarian cancer. Am J Epidemiol 145 (1997) 459-465
44. Paulson R.J. Fertility drugs and ovarian epithelial cancer: the endometriosis hypothesis. J Assist Reprod Genet 14 (1997) 228-230
45. Brinton L.A., Lamb E.J., Moghissi K.S., Scoccia B., Althuis M.D., Mabie J.E., et al. Ovarian cancer risk after the use of ovulation-stimulating drugs. Obstet Gynecol 103 6 (2004 Jun) 1194-1203
46. Klip H., Burger C.W., Leeuwen V., and the Omega Project Group. Risk of hormone-related cancers after ovarian stimulation for in-vitro fertilization in a cohort of 25,152 women. In: Klip H. (Ed). Long-term health effects of subfertility treatment (2002), PrintPartners Ipskamp B.V. Enschede, the Netherlands 55-82
47. Shu X.O., Brinton L.A., Gao Y.T., and Yuan J.M. Population-based case-control study of ovarian cancer in Shanghai. Cancer Res 49 13 (1989 July 1) 3670-3674
48. Franceschi S., La Vecchia C., Negri E., Guarneri S., Montella M., Conti E., et al. Fertility drugs and risk of epithelial ovarian cancer in Italy. Hum Reprod 9 9 (1994 Sep) 1673-1675
49. Parazzini F., Negri E., La Vecchia C., Moroni S., Franceschi S., and Crosignani P.G. Treatment for infertility and risk of invasive epithelial ovarian cancer. Hum Reprod 12 10 (1997 Oct) 2159-2161
50. Miannay E., Boutemy J.J., Leroy-Billiard M., Gasnault J.P., and Leroy J.L. The possible endometrial risk of ovarian stimulation. Apropos of 3 cases. J Gynecol Obstet Biol Reprod (Paris) 23 1 (1994) 35-38
51. Althuis M.D., Moghissi K.S., Westhoff C.L., Scoccia B., Lamb E.J., Lubin J.H., et al. Uterine cancer after use of clomiphene citrate to induce ovulation. Am J Epidemiol 161 7 (2005 Apr 1) 607-615
52. Doyle P., Maconochie N., Beral V., Swerdlow A.J., and Tan S.L. Cancer incidence following treatment for infertility at a clinic in the UK. Hum Reprod 17 (2002) 2209-2213
53. Lerner-Geva L., Geva E., Lessing J., Chetrit A., Modan B., and Amit A. The possible association between in vitro fertilization treatments and cancer development. Int J Gynecol Cancer 13 (2003) 23-27
54. Braga C., Negri E., La Vecchia C., Parazzini F., Dal Masso L., and Franceschi S. Fertility treatment and risk of breast cancer. Hum Reprod 11 (1996) 300-303
55. Ricci E., Parazzini F., Negri E., Marsico S., and La Vecchia C. Fertility drugs and the risk of breast cancer. Hum Reprod 14 (1999) 1653-1655
56. Weiss H.A., Troisi R., Rossing M.A., Brogan D., Coates R.J., Gammon M.D., et al. Fertility problems and breast cancer risk in young women: a case-control study in the United States. Cancer Causes Control 9 (1998) 331-339
57. Burkman R.T., Tang M.T., Malone K.E., Marchbanks P.A., McDonald J.A., Folger S.G., et al. Infertility drugs and the risk of breast cancer: findings from the National Institute of Child Health and Human Development Women's Contraceptive and Reproductive Experiences Study. Fertil Steril 79 4 (2003 Apr) 844-851
58. Gauthier E., Paoletti X., Clavel-Chapelon F., and E3N group. Breast cancer risk associated with being treated for infertility: results from the French E3N cohort study. Hum Reprod 19 10 (2004 Oct) 2216-2221
59. Rossing M.A., Daling J.R., Weiss N.S., Moore D.E., and Self S.G. Risk of breast cancer in a cohort in infertile women. Gynecol Oncol 60 1 (1996 Jan) 3-7
60. Terry K.L., Willett W.C., Rich-Edwards J.W., and Michels K.B. Clomiphene citrate use and reduced incidence of premenopausal breast cancer. Am J Epidemiol 159 Suppl. 66 (2004) 2615
61. Lerner-Geva L., Keinan-Boker L., Blumstein T., Boyko V., Olmar L., Mashiach S., et al. Infertility, ovulation induction treatments and the incidence of breast cancer - a historical prospective cohort of Israeli women. Breast Cancer Res Treat 100 2 (2006 Nov) 201-212 [Epub 2006 May 10]
62. Young P., Purdie D., Jackman L., Molloy D., and Green A. A study of infertility treatment and melanoma. Melanoma Res 11 (2001) 535-541
63. Althuis M.D., Scoccia B., Lamb E.J., Moghissi K.S., Westhoff C.L., Mabie J.E., et al. Melanoma, thyroid, cervical, and colon cancer risk after use of fertility drugs. Am J Obstet Gynecol 193 3 Pt 1 (2005 Sep) 668-674
64. Kolonel L.N., Hankin J.H., Wilkens L.R., Fukunaga F.H., and Hinds M.W. An epidemiologic study of thyroid cancer in Hawaii. Cancer Causes Control 1 (1990) 223-234
65. La Vecchia C., Ron E., Franceschi S., Dal Maso L., Mark S.D., Chatenoud L., et al. A pooled analysis of case control studies of thyroid cancer III, oral contraceptives, menopausal replacement therapy and other female hormones. Cancer Causes Control 10 (1999) 157-166
66. Hannibal C.G., Jensen A., Sharif H., and Kjaer S.K. Risk of thyroid cancer after exposure to fertility drugs: results from a large Danish cohort study. Hum Reprod 23 2 (2008 Feb) 451-456